Report Details

According to the report published by the Market Research Store, global demand for the acne drug market was estimated at approximately USD 12,300.8 Million in 2020 and is expected to generate revenue of around USD 13,100.7 Million by the end of 2026, growing at a CAGR of around 3.6% between 2021 and 2026.

Global Acne Drug Market: Overview

Acne affects more than 90 percent of the world's population at some point in their lives. This includes all levels of acne, from mild, infrequent breakouts to severe conditions. Twenty percent of the 60 million suffer from acne severe enough to cause skin scarring. Acne medications are medications that are prescribed to treat acne. Prescription and over-the-counter medications such as retinoids, isotretinoin, antibiotics, salicylic acid, benzoyl peroxide, and oral contraceptives fall under acne medications. The acne drug market consists of prescription drugs like onexton, solodyn, retin. A micro and non-prescription drugs like cleanser, retainers, lotions, etc. are used to treat skin diseases. The best treatments limit bacterial growth, promote skin cell shedding to unclog pores, use a newer treatment that blocks male hormones in the skin.

Global Acne Drug Market: Growth Factor

The rise in the prevalence of acne diseases is a major factor driving the growth of the acne medication market. Furthermore, other factors driving the market include an unhealthy urban lifestyle and the presence of potent acne medications in the pipeline. However, the presence of alternative treatments and the side effects associated with the use of acne medications impede the market growth. In contrast, the development of effective medications and high market potential in emerging economies is expected to provide growth opportunities for the market.

Furthermore, rapid economic growth has resulted in a significant increase in the disposable incomes of middle-class people. People are willing to spend more money on their facial appearance as their income rises. As a result, the market for acne therapeutics is expected to expand rapidly during the forecast period.

REPORT SNAPSHOT & REPORTING DATA TIMEFRAME
Parameter Details
Historical Date ( Actual Data) 2016 - 2020
Base Year Data 2020
Current Year Data 2021
Projected Data 2021 - 2026
Report coverage Revenue forecast, company ranking, competitive landscape, growth factors, and trends
Segments covered product type, application, region
Regional scope North America; Europe; Asia Pacific; Central & South America; Middle East & Africa
Country Scope U.S.; Canada; Mexico; Germany; France; U.K.; China; Japan; South Korea; Singapore; Malaysia; Brazil; Saudi Arabia
Customization scope Free report customization (equivalent to up to 8 analysts working days) with purchase. Addition or alteration to country, regional & segment scope.
Pricing and purchase options Avail customized purchase options to meet your exact research needs. Explore purchase options

Global Acne Drug Market: Segmentation

The acne drug market is divided into four categories: formulation type, therapeutic class, acne type, and distribution channel. The market is divided into therapeutic segments such as retinoids, antibiotics, salicylic acid, and benzoyl peroxide, and others. The therapeutic segment of retinoids is further subdivided into the topical, combination, and oral retinoid. The market is divided into two segments based on formulation: topical medication and oral medication. It is classified into two types: over-the-counter and prescription medication. Acne is divided into inflammatory and non-inflammatory acne, according to acne segmentation. By distribution channel, it is distributed to into retail store, pharmacy & drug store, and e-commerce.

Global Acne Drug Market: Regional Analysis

North America dominates the acne medication market as a result of an increase in concern for facial aesthetics in the American region, as well as increased awareness and availability of better acne treatment options, as well as an increase in spending on facial appearances.

It is expected to grow at a faster CAGR in the Asia-Pacific region during the forecast period. This is due to a greater understanding of treatment options. Increased disposable income, rising acne disorder prevalence, and the availability of acne treatment options concerns about facial beauty among the population in countries like China and India, as well as an increase in unhealthy eating habits, are driving the growth of the industry.

Global Acne Drug Market: Competitive Players

To broaden their product and service offerings, expand their global footprint, and increase their market share, the leading companies have used a variety of strategies. The majority of companies in the global acne drug market used new product launches as their primary strategy, allowing them to expand their product offerings while maintaining a competitive edge in the global acne drug market.

Major players in the acne drugs market are Allergan, Teva Pharmaceutical Industries Ltd., Valeant Pharmaceutical International Inc., Galderma S.A., and Johnson & Johnson Services, Inc.

For instance, Teva Pharmaceutical Industries Ltd. also known as Teva Pharmaceuticals is a global pharmaceutical company that specializes primarily in generic drugs, but other business interests include active pharmaceutical ingredients. It is the largest generic drug manufacturer in the world and one of the 15 largest pharmaceutical companies worldwide. In 2015, the company announced it would collaborate with Heptares Therapeutics with its work on small-molecule calcitonin gene-related peptide antagonists for migraine treatment, with the deal generating up to $410 million.

Global Acne Drug Market: By Therapeutic Class

  • Retinoid
  • Antibiotic
  • Salicylic Acid
  • Benzoyl Peroxide
  • Others

Global Acne Drug Market, By Formulation

  • Topical Medications
  • Oral Medications

Global Acne Drug Market: By Type

  • Prescription Medicines
  • Over-The-Counter Medicines

Global Acne Drug Market: By Distribution Channel

  • Retail Stores
  • Pharmacies & Drug Stores
  • E-Commerce

Global Acne Drug Market: By Regional Segmentation Analysis

  • North America
    • U.S.
    • Canada
  • Europe
    • Germany
    • The UK
    • France
    • Spain
    • Italy
    • Rest of Europe
  • Asia Pacific
    • China
    • Japan
    • India
    • South Korea
    • Southeast Asia
    • Rest of Asia Pacific
  • Latin America
    • Brazil
    • Mexico
    • Rest of Latin America
  • Middle East & Africa
    • GCC Countries
    • South Africa
    • Rest of Middle East & Africa

 

Frequently Asked Questions

What are the key factors driving global acne drug market expansion?

The rise in economic growth, increase in prevalence, and development of new technologies in the drug market are key factors of acne drug market expansion.

What will be the value of the acne drug market during 2021- 2026?

The global demand for the acne drug market was estimated at approximately USD 12,300.8 Million in 2020 and is expected to generate revenue of around USD 13,100.7 Million by the end of 2026, growing at a CAGR of around 3.6% between 2021 and 2026.

Which region will make notable contributions towards global acne drug market revenue?

North America dominating the acne drug market due to its large-scale impact on the target disorder. Moreover, Asia-Pacific is predicted to observe the highest growth rate out of all the regions due to the increase in patients who are suffering from this disorder.

What are the key players leveraging acne drug market growth?

Major players in the acne drugs market are Allergan, Teva Pharmaceutical Industries Ltd. Valeant Pharmaceutical International Inc., Galderma S.A., and Johnson & Johnson Services, Inc.

Table Of Content

  • Chapter 1 Executive Summary
    • 1.1. Introduction of Acne Drug
    • 1.2. Global Acne DrugMarket, 2020 & 2026 (USD Million)
    • 1.3. Global Acne Drug Market, 2016 – 2026(USD Million)
    • 1.4. Global Acne Drug MarketAbsulute Revenue Opportunity, 2016 – 2026(USD Million)
    • 1.5. Global Acne Drug MarketIncremental Revenue Opportunity, 2020 – 2026(USD Million)
  • Chapter 2 Acne DrugMarket – Therapeutic Class Analysis
    • 2.1. Global Acne Drug Market – Therapeutic Class Overview
    • 2.2. Global Acne Drug Market Share, by Therapeutic Class, 2020 & 2026(USD Million)
    • 2.3. Retinoids
      • 2.3.1. Global RetinoidsAcne Drug Market, 2016 – 2026(USD Million)
    • 2.4. Antibiotics
      • 2.4.1. Global AntibioticsAcne Drug Market, 2016 – 2026(USD Million)
    • 2.5. Salicylic Acid
      • 2.5.1. Global Salicylic AcidAcne Drug Market, 2016 – 2026(USD Million)
    • 2.6. Benzoyl Peroxide
      • 2.6.1. Global Benzoyl PeroxideAcne Drug Market, 2016 – 2026(USD Million)
    • 2.7. Others
      • 2.7.1. Global OthersAcne Drug Market, 2016 – 2026(USD Million)
  • Chapter 3 Acne DrugMarket – Formulation Analysis
    • 3.1. Global Acne Drug Market – Formulation Overview
    • 3.2. Global Acne Drug Market Share, by Formulation, 2020 & 2026(USD Million)
    • 3.3. Topical Medications
      • 3.3.1. Global Topical MedicationsAcne Drug Market, 2016 – 2026(USD Million)
    • 3.4. Oral Medications
      • 3.4.1. Global Oral MedicationsAcne Drug Market, 2016 – 2026(USD Million)
  • Chapter 4 Acne DrugMarket – Type Analysis
    • 4.1. Global Acne Drug Market – Type Overview
    • 4.2. Global Acne Drug Market Share, by Type, 2020 & 2026(USD Million)
    • 4.3. Prescription Medicines
      • 4.3.1. Global Prescription MedicinesAcne Drug Market, 2016 – 2026(USD Million)
    • 4.4. Over-The-Counter Medicines
      • 4.4.1. Global Over-The-Counter MedicinesAcne Drug Market, 2016 – 2026(USD Million)
  • Chapter 5 Acne DrugMarket – Distribution Channel Analysis
    • 5.1. Global Acne Drug Market – Distribution Channel Overview
    • 5.2. Global Acne Drug Market Share, by Distribution Channel, 2020 & 2026(USD Million)
    • 5.3. Retail Stores
      • 5.3.1. Global Retail StoresAcne Drug Market, 2016 – 2026(USD Million)
    • 5.4. Pharmacies
      • 5.4.1. Global PharmaciesAcne Drug Market, 2016 – 2026(USD Million)
    • 5.5. Drug Stores
      • 5.5.1. Global Drug StoresAcne Drug Market, 2016 – 2026(USD Million)
    • 5.6. E-Commerce
      • 5.6.1. Global E-CommerceAcne Drug Market, 2016 – 2026(USD Million)
  • Chapter 6 Acne DrugMarket – Regional Analysis
    • 6.1. Global Acne Drug Market Regional Overview
    • 6.2. Global Acne Drug Market Share, by Region, 2020 & 2026(USD Million)
    • 6.3. North America
      • 6.3.1. North AmericaAcne Drug Market, 2016 – 2026(USD Million)
        • 6.3.1.1. North AmericaAcne Drug Market, by Country, 2016 - 2026(USD Million)
      • 6.3.2. North AmericaAcne Drug Market, by Therapeutic Class, 2016 – 2026
        • 6.3.2.1. North AmericaAcne Drug Market, by Therapeutic Class, 2016 – 2026(USD Million)
      • 6.3.3. North AmericaAcne Drug Market, by Formulation, 2016 – 2026
        • 6.3.3.1. North AmericaAcne Drug Market, by Formulation, 2016 – 2026(USD Million)
      • 6.3.4. North AmericaAcne Drug Market, by Type, 2016 – 2026
        • 6.3.4.1. North AmericaAcne Drug Market, by Type, 2016 – 2026(USD Million)
      • 6.3.5. North AmericaAcne Drug Market, by Distribution Channel, 2016 – 2026
        • 6.3.5.1. North AmericaAcne Drug Market, by Distribution Channel, 2016 – 2026(USD Million)
      • 6.3.6. U.S.
        • 6.3.6.1. U.S.Acne DrugMarket, 2016 – 2026(USD Million)
      • 6.3.7. Canada
        • 6.3.7.1. CanadaAcne DrugMarket, 2016 – 2026(USD Million)
    • 6.4. Europe
      • 6.4.1. EuropeAcne Drug Market, 2016 – 2026(USD Million)
        • 6.4.1.1. EuropeAcne Drug Market, by Country, 2016 - 2026(USD Million)
      • 6.4.2. EuropeAcne Drug Market, by Therapeutic Class, 2016 – 2026
        • 6.4.2.1. EuropeAcne Drug Market, by Therapeutic Class, 2016 – 2026(USD Million)
      • 6.4.3. EuropeAcne Drug Market, by Formulation, 2016 – 2026
        • 6.4.3.1. EuropeAcne Drug Market, by Formulation, 2016 – 2026(USD Million)
      • 6.4.4. EuropeAcne Drug Market, by Type, 2016 – 2026
        • 6.4.4.1. EuropeAcne Drug Market, by Type, 2016 – 2026(USD Million)
      • 6.4.5. EuropeAcne Drug Market, by Distribution Channel, 2016 – 2026
        • 6.4.5.1. EuropeAcne Drug Market, by Distribution Channel, 2016 – 2026(USD Million)
      • 6.4.6. Germany
        • 6.4.6.1. GermanyAcne DrugMarket, 2016 – 2026(USD Million)
      • 6.4.7. France
        • 6.4.7.1. FranceAcne DrugMarket, 2016 – 2026(USD Million)
      • 6.4.8. U.K.
        • 6.4.8.1. U.K.Acne DrugMarket, 2016 – 2026(USD Million)
      • 6.4.9. Italy
        • 6.4.9.1. ItalyAcne DrugMarket, 2016 – 2026(USD Million)
      • 6.4.10. Spain
        • 6.4.10.1. SpainAcne DrugMarket, 2016 – 2026(USD Million)
      • 6.4.11. Rest of Europe
        • 6.4.11.1. Rest of EuropeAcne DrugMarket, 2016 – 2026(USD Million)
    • 6.5. Asia Pacific
      • 6.5.1. Asia PacificAcne Drug Market, 2016 – 2026(USD Million)
        • 6.5.1.1. Asia PacificAcne Drug Market, by Country, 2016 - 2026(USD Million)
      • 6.5.2. Asia PacificAcne Drug Market, by Therapeutic Class, 2016 – 2026
        • 6.5.2.1. Asia PacificAcne Drug Market, by Therapeutic Class, 2016 – 2026(USD Million)
      • 6.5.3. Asia PacificAcne Drug Market, by Formulation, 2016 – 2026
        • 6.5.3.1. Asia PacificAcne Drug Market, by Formulation, 2016 – 2026(USD Million)
      • 6.5.4. Asia PacificAcne Drug Market, by Type, 2016 – 2026
        • 6.5.4.1. Asia PacificAcne Drug Market, by Type, 2016 – 2026(USD Million)
      • 6.5.5. Asia PacificAcne Drug Market, by Distribution Channel, 2016 – 2026
        • 6.5.5.1. Asia PacificAcne Drug Market, by Distribution Channel, 2016 – 2026(USD Million)
      • 6.5.6. China
        • 6.5.6.1. ChinaAcne DrugMarket, 2016 – 2026(USD Million)
      • 6.5.7. Japan
        • 6.5.7.1. JapanAcne DrugMarket, 2016 – 2026(USD Million)
      • 6.5.8. India
        • 6.5.8.1. IndiaAcne DrugMarket, 2016 – 2026(USD Million)
      • 6.5.9. South Korea
        • 6.5.9.1. South KoreaAcne DrugMarket, 2016 – 2026(USD Million)
      • 6.5.10. South-East Asia
        • 6.5.10.1. South-East AsiaAcne DrugMarket, 2016 – 2026(USD Million)
      • 6.5.11. Rest of Asia Pacific
        • 6.5.11.1. Rest of Asia PacificAcne DrugMarket, 2016 – 2026(USD Million)
    • 6.6. Latin America
      • 6.6.1. Latin AmericaAcne Drug Market, 2016 – 2026(USD Million)
        • 6.6.1.1. Latin AmericaAcne Drug Market, by Country, 2016 - 2026(USD Million)
      • 6.6.2. Latin AmericaAcne Drug Market, by Therapeutic Class, 2016 – 2026
        • 6.6.2.1. Latin AmericaAcne Drug Market, by Therapeutic Class, 2016 – 2026(USD Million)
      • 6.6.3. Latin AmericaAcne Drug Market, by Formulation, 2016 – 2026
        • 6.6.3.1. Latin AmericaAcne Drug Market, by Formulation, 2016 – 2026(USD Million)
      • 6.6.4. Latin AmericaAcne Drug Market, by Type, 2016 – 2026
        • 6.6.4.1. Latin AmericaAcne Drug Market, by Type, 2016 – 2026(USD Million)
      • 6.6.5. Latin AmericaAcne Drug Market, by Distribution Channel, 2016 – 2026
        • 6.6.5.1. Latin AmericaAcne Drug Market, by Distribution Channel, 2016 – 2026(USD Million)
      • 6.6.6. Brazil
        • 6.6.6.1. BrazilAcne DrugMarket, 2016 – 2026(USD Million)
      • 6.6.7. Mexico
        • 6.6.7.1. MexicoAcne DrugMarket, 2016 – 2026(USD Million)
      • 6.6.8. Rest of Latin America
        • 6.6.8.1. Rest of Latin AmericaAcne DrugMarket, 2016 – 2026(USD Million)
    • 6.7. The Middle-East and Africa
      • 6.7.1. The Middle-East and AfricaAcne Drug Market, 2016 – 2026(USD Million)
        • 6.7.1.1. The Middle-East and AfricaAcne Drug Market, by Country, 2016 - 2026(USD Million)
      • 6.7.2. The Middle-East and AfricaAcne Drug Market, by Therapeutic Class, 2016 – 2026
        • 6.7.2.1. The Middle-East and AfricaAcne Drug Market, by Therapeutic Class, 2016 – 2026(USD Million)
      • 6.7.3. The Middle-East and AfricaAcne Drug Market, by Formulation, 2016 – 2026
        • 6.7.3.1. The Middle-East and AfricaAcne Drug Market, by Formulation, 2016 – 2026(USD Million)
      • 6.7.4. The Middle-East and AfricaAcne Drug Market, by Type, 2016 – 2026
        • 6.7.4.1. The Middle-East and AfricaAcne Drug Market, by Type, 2016 – 2026(USD Million)
      • 6.7.5. The Middle-East and AfricaAcne Drug Market, by Distribution Channel, 2016 – 2026
        • 6.7.5.1. The Middle-East and AfricaAcne Drug Market, by Distribution Channel, 2016 – 2026(USD Million)
      • 6.7.6. GCC Countries
        • 6.7.6.1. GCC CountriesAcne DrugMarket, 2016 – 2026(USD Million)
      • 6.7.7. South Africa
        • 6.7.7.1. South AfricaAcne DrugMarket, 2016 – 2026(USD Million)
      • 6.7.8. Rest of Middle-East Africa
        • 6.7.8.1. Rest of Middle-East AfricaAcne DrugMarket, 2016 – 2026(USD Million)
  • Chapter 7 Acne DrugMarket – Competitive Landscape
    • 7.1. Competitor Market Share – Revenue
    • 7.2. Market Concentration Rate Analysis, Top 3 and Top 5 Players
    • 7.3. Strategic Developments
      • 7.3.1. Acquisitions and Mergers
      • 7.3.2. New Products
      • 7.3.3. Research & Development Activities
  • Chapter 8 Company Profiles
    • 8.1. Allergan
      • 8.1.1. Company Overview
      • 8.1.2. Product/ServicePortfulio
      • 8.1.3. Allergan Sales, Revenue, and Gross Margin
      • 8.1.4. Allergan Revenue and Growth Rate
      • 8.1.5. Allergan Market Share
      • 8.1.6. Recent Initiatives, Funding/VC Activities, and Technulogical Innovations
    • 8.2. Teva Pharmaceutical Industries Ltd. Valeant Pharmaceutical International Inc.
      • 8.2.1. Company Overview
      • 8.2.2. Product/ServicePortfulio
      • 8.2.3. Teva Pharmaceutical Industries Ltd. Valeant Pharmaceutical International Inc. Sales, Revenue, and Gross Margin
      • 8.2.4. Teva Pharmaceutical Industries Ltd. Valeant Pharmaceutical International Inc. Revenue and Growth Rate
      • 8.2.5. Teva Pharmaceutical Industries Ltd. Valeant Pharmaceutical International Inc. Market Share
      • 8.2.6. Recent Initiatives, Funding/VC Activities, and Technulogical Innovations
    • 8.3. Galderma S.A.
      • 8.3.1. Company Overview
      • 8.3.2. Product/ServicePortfulio
      • 8.3.3. Galderma S.A. Sales, Revenue, and Gross Margin
      • 8.3.4. Galderma S.A. Revenue and Growth Rate
      • 8.3.5. Galderma S.A. Market Share
      • 8.3.6. Recent Initiatives, Funding/VC Activities, and Technulogical Innovations
    • 8.4. Johnson & Johnson Services
      • 8.4.1. Company Overview
      • 8.4.2. Product/ServicePortfulio
      • 8.4.3. Johnson & Johnson Services Sales, Revenue, and Gross Margin
      • 8.4.4. Johnson & Johnson Services Revenue and Growth Rate
      • 8.4.5. Johnson & Johnson Services Market Share
      • 8.4.6. Recent Initiatives, Funding/VC Activities, and Technulogical Innovations
      • 8.5. Inc.
      • 8.5.1. Company Overview
      • 8.5.2. Product/ServicePortfulio
        • 8.5.3. Inc. Sales, Revenue, and Gross Margin
        • 8.5.4. Inc. Revenue and Growth Rate
        • 8.5.5. Inc. Market Share
      • 8.5.6. Recent Initiatives, Funding/VC Activities, and Technulogical Innovations
  • Chapter 9 Acne Drug — Industry Analysis
    • 9.1. Introduction and Taxonomy
    • 9.2. Acne Drug Market – Key Trends
      • 9.2.1. Market Drivers
      • 9.2.2. Market Restraints
      • 9.2.3. Market Opportunities
    • 9.3. Value Chain Analysis
    • 9.4. Key Mandates and Regulations
    • 9.5. Technulogy Roadmap and Timeline
    • 9.6. Acne DrugMarket – Attractiveness Analysis
      • 9.6.1. By Therapeutic Class
      • 9.6.2. By Formulation
      • 9.6.3. By Type
      • 9.6.4. By Distribution Channel
      • 9.6.5. By Region
  • Chapter 10 Industrial Chain, Sourcing Strategy, and Downstream Buyers
    • 10.1. Acne Drug Industrial Chain Analysis
    • 10.2. Downstream Buyers
    • 10.3. Distributors/Traders List
  • Chapter 11 Marketing Strategy Analysis
    • 11.1. Marketing Channel
    • 11.2. Direct Marketing
    • 11.3. Indirect Marketing
    • 11.4. Marketing Channel Development Trends
    • 11.5. Economic/Pulitical Environmental Change
  • Chapter 12 Report Conclusion& Key Insights
    • 12.1. Key Insights from Primary Interviews & Surveys Respondents
    • 12.2. Key Takeaways from Analysts, Consultants, and Industry Leaders
  • Chapter 13 Research Approach & Methodulogy
    • 13.1. Report Description
    • 13.2. Research Scope
    • 13.3. Research Methodulogy
      • 13.3.1. Secondary Research
      • 13.3.2. Primary Research
      • 13.3.3. Statistical Models
        • 13.3.3.1. Company Share Analysis Model
        • 13.3.3.2. Revenue Based Modeling
      • 13.3.4. Research Limitations

Inquiry For Buying

Acne Drug

Please fill out the form. We will contact you within 24 hours:
All fields required...

Request Sample

Acne Drug

Please fill out the form. We will contact you within 24 hours:
All fields required...
Inquiry For Buying

×

Avail Free PDF Sample Report

This website is secure and your personal details are safe. Privacy Policy

Thank you for contacting us.

Thank you for your interest in our research report.

We will be sending you the sample copy of the report shortly. Meanwhile, if you have any specific research requirement then please let us know. We will be glad to assist you in case you have any additional questions, so feel free to get in touch

Thank you


Warm regards,
Sales | Manager - International Business and partner Relations
Direct line: +1 347 535 0815
Market Research Store
E-mail: sales@MarketResearchStore.com | Web: www.MarketResearchStore.com